Key result
Arterial hypertension is linked to significantly higher oxidative DNA damage compared to healthy controls.
Why the study?
Is oxidative DNA damage higher in arterial hypertension compared to healthy controls?
Systematic Review (n=1,489)
Is oxidative DNA damage higher in arterial hypertension compared to healthy controls?
Oxidative DNA damage is consistently increased in arterial hypertension across human, animal, and cell-line studies, suggesting a potential pathophysiological mechanism and therapeutic target.
Introduction Three types of oxidative DNA damage ((oxidised guanosine/8OHdG, Single strand breaks (SSBs)/comet assay, Double strand breaks (DSBs)/gammaH2AX)) are becoming tested more frequently in clinical cardiology research (Picture 1). Epidemiology of arterial hypertension /HT/ is not optimal. Purpose To describe systematically the most severe DNA damage in HT (humans, animals, cell-lines). Methods This review on DNA damage in HT was made using multiple databases to search for English-language publications up to June 30, 2022 and the key words: DNA damage, 8OHdG, strand breaks, comet assay, gammaH2AX and HT. Inclusion, exclusion criteria, flow diagram (Picture 1). Results Finally, N=31 studies: (N=15 humans, N=13 animals, N=3 cells) (Picture 1). A total of 902 hypertensive patients (pts): (8OHdG: N=484 pts; SSBs: N=418 pts) and 587 controls (8OHdG: N=384; SSBs: N=203) were included. DNA damage was significantly higher in hypertensive pts than healthy controls (8OHdG 13.1±4.12 vs 6.97±2.67 ng.mg-1 creatinine; P<0.05 and SSBs 26.6±11.0 vs 11.7±4.07 arbitrary units /A.U./; P<0.05) with the average mean differences and 95% confidence limit (MD /95%CL) 7.5 /6.6; 8.6/ ng.mg-1 creatinine for 8OHdG in urine, respectively 14.7 /6.4; 23.0/ A.U. for SSBs in peripheral lymphocytes. Greater DNA damage was observed in more adverse cases (sustained/untreated hypertension 31.4±12.1 vs 14.2±5/35.0±5.0 vs 25.0±5.0; non-dippers 39.2±15.5 vs 29.4±11.1 A.U.; concentric cardiac hypertrophy 43.4±15.4 vs 15.6±5.5; elderly 14.9±4.5 vs 9.3±4.1 ng.mg-1 creatinine; without carvedilol 9.1±4.2 vs 5.7±3.9; with coronary heart disease 0.5±0.1 vs 0.2±0.1 ng.mL-1) (P<0.05) with the average MD /95% CL/ 3.4 /0.8;5.9/ ng.mg-1 creatinine for 8OHdG in urine, respectively 16.1 /12.1; 20.1/ A.U. for SSBs in peripheral lymphocytes. DNA damage correlated strongly positively with serum glycosylated haemoglobin (r=0.670; P<0.05) and negatively with total antioxidant status (r=−0.670 to −0.933; P<0.05). Higher DNA damage (8OHdG, SSBs, DSBs; P<0.05) in HT than in controls was consistently seen also under strictly experimental conditions (animals; cell-lines). Conclusion This is the first review showing systematically that oxidative DNA damage was consistently increased in HT individuals compared to controls (humans, animals, cell-lines) (Ref 1;2). The author believes that this finding can help at least partially fill in the gaps in the evidence, it can be a further piece in the pathophysiological subcellular mosaic (unrepaired harmful DNA in the cytosol when the reparation and defences are exceeded, cytosolic DNA sensors are activated) (Ref 3;5). Thus author believes, that this finding could represent a new therapeutic challenge (DNA damage response substances like a target) (Ref 4;5). First of all, everything must be thoroughly and repeatedly investigated with the caution for pharmacotherapy (Ref 1;2), which can unfortunately affect the results of DNA damage (Ref 1;6).
No takes yet. Share an insight, caveat, or question.
Hazuková et al. (2025) conducted a systematic review in Arterial hypertension (n=1,489). Arterial hypertension vs. Healthy controls was evaluated on 8OHdG in urine (MD 7.5, 95% CI 6.6-8.6, p=<0.05). Arterial hypertension was associated with significantly higher oxidative DNA damage compared to healthy controls, including 8OHdG (MD 7.5; 95% CI 6.6-8.6) and SSBs (MD 14.7; 95% CI 6.4-23.0).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: